| FEV1% predicted (%) | P for trend | ||
---|---|---|---|---|
Tertile 1 | Tertile 2 | Tertile 3 | ||
Men | ||||
 Range, % | > 101.5 | 87.0–101.5 | < 87.0 |  |
 Number of participants | 251 | 251 | 251 |  |
 Presence of arterial stiffness, n (%) | 174 (69.3) | 181 (72.1) | 202 (80.5) |  |
 Crude OR (95% CI) | 1.00 | 1.14 (0.78–1.68) | 1.82 (1.21–2.75)** | 0.005 |
 Adjusted OR (95% CI) | 1.00 | 1.20 (0.77–1.89) | 1.75 (1.05–2.92)* | 0.03 |
 Presence of PAD, n (%) | 4 (1.6) | 5 (2.0) | 7 (2.8) |  |
 Crude OR (95% CI) | 1.00 | 1.26 (0.33–4.73) | 1.77 (0.51–6.13) | 0.36 |
 Adjusted OR (95% CI) | 1.00 | 1.18 (0.31–4.57) | 1.61 (0.42–6.16) | 0.48 |
Women | ||||
 Range, % | > 105.7 | 94.1–105.7 | < 94.1 |  |
 Number of participants | 258 | 258 | 259 |  |
 Presence of arterial stiffness, n (%) | 120 (46.5) | 150 (58.1) | 153 (59.1) |  |
 Crude OR (95% CI) | 1.00 | 1.60 (1.13–2.26)** | 1.66 (1.17–2.35)** | 0.004 |
 Adjusted OR (95% CI) | 1.00 | 1.50 (0.99–2.27) | 1.28 (0.83–1.96) | 0.25 |
 Presence of PAD, n (%) | 2 (0.8) | 3 (1.2) | 8 (3.1) |  |
 Crude OR (95% CI) | 1.00 | 1.51 (0.25–9.09) | 4.08 (0.86–19.40) | 0.05 |
 Adjusted OR (95% CI) | 1.00 | 1.08 (0.17–7.12) | 1.62 (0.27–9.67) | 0.56 |